Emma R. Perri

480 total citations
9 papers, 288 citations indexed

About

Emma R. Perri is a scholar working on Neurology, Cell Biology and Epidemiology. According to data from OpenAlex, Emma R. Perri has authored 9 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Neurology, 7 papers in Cell Biology and 3 papers in Epidemiology. Recurrent topics in Emma R. Perri's work include Amyotrophic Lateral Sclerosis Research (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Emma R. Perri is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (8 papers), Endoplasmic Reticulum Stress and Disease (6 papers) and Parkinson's Disease Mechanisms and Treatments (5 papers). Emma R. Perri collaborates with scholars based in Australia and Uruguay. Emma R. Perri's co-authors include Julie D. Atkin, Sonam Parakh, Damian M. S. Spencer, Colleen J. Thomas, Audrey Ragagnin, Cyril J. Jagaraj, Marta Vidal, Anna Konopka, Adam K. Walker and Hamideh Shahheydari and has published in prestigious journals such as Scientific Reports, Human Molecular Genetics and Critical Reviews in Biochemistry and Molecular Biology.

In The Last Decade

Emma R. Perri

9 papers receiving 281 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emma R. Perri Australia 8 142 115 115 51 47 9 288
Pablo Rozas Chile 10 127 0.9× 141 1.2× 127 1.1× 68 1.3× 46 1.0× 14 357
Marta Vidal Australia 8 50 0.4× 109 0.9× 171 1.5× 52 1.0× 83 1.8× 12 326
Elena Casarotto Italy 10 74 0.5× 149 1.3× 65 0.6× 45 0.9× 34 0.7× 16 238
Marta Chierichetti Italy 10 74 0.5× 149 1.3× 65 0.6× 45 0.9× 34 0.7× 16 238
Mümine Şentürk United States 8 84 0.6× 156 1.4× 101 0.9× 117 2.3× 24 0.5× 10 337
Ryan Prestil United States 6 83 0.6× 255 2.2× 94 0.8× 116 2.3× 36 0.8× 8 445
Jinzhi Zhang China 5 64 0.5× 146 1.3× 146 1.3× 59 1.2× 47 1.0× 5 373
Maxinne Watchon Australia 8 44 0.3× 160 1.4× 64 0.6× 40 0.8× 37 0.8× 13 258
Britta Eggers Germany 10 106 0.7× 188 1.6× 35 0.3× 18 0.4× 17 0.4× 22 299
Linhao Ruan United States 8 149 1.0× 416 3.6× 82 0.7× 71 1.4× 17 0.4× 13 543

Countries citing papers authored by Emma R. Perri

Since Specialization
Citations

This map shows the geographic impact of Emma R. Perri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma R. Perri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma R. Perri more than expected).

Fields of papers citing papers by Emma R. Perri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emma R. Perri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma R. Perri. The network helps show where Emma R. Perri may publish in the future.

Co-authorship network of co-authors of Emma R. Perri

This figure shows the co-authorship network connecting the top 25 collaborators of Emma R. Perri. A scholar is included among the top collaborators of Emma R. Perri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emma R. Perri. Emma R. Perri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Parakh, Sonam, Emma R. Perri, Marta Vidal, et al.. (2024). Protein Disulfide Isomerase Endoplasmic Reticulum Protein 57 (ERp57) is Protective Against ALS-Associated Mutant TDP-43 in Neuronal Cells. NeuroMolecular Medicine. 26(1). 23–23. 4 indexed citations
2.
Parakh, Sonam, Emma R. Perri, Marta Vidal, et al.. (2021). Protein disulphide isomerase (PDI) is protective against amyotrophic lateral sclerosis (ALS)-related mutant Fused in Sarcoma (FUS) in in vitro models. Scientific Reports. 11(1). 17557–17557. 8 indexed citations
3.
Perri, Emma R., Sonam Parakh, Marta Vidal, et al.. (2020). The Cysteine (Cys) Residues Cys-6 and Cys-111 in Mutant Superoxide Dismutase 1 (SOD1) A4V Are Required for Induction of Endoplasmic Reticulum Stress in Amyotrophic Lateral Sclerosis. Journal of Molecular Neuroscience. 70(9). 1357–1368. 7 indexed citations
4.
Parakh, Sonam, Sina Shadfar, Emma R. Perri, et al.. (2020). The Redox Activity of Protein Disulfide Isomerase Inhibits ALS Phenotypes in Cellular and Zebrafish Models. iScience. 23(5). 101097–101097. 28 indexed citations
5.
Parakh, Sonam, Emma R. Perri, Cyril J. Jagaraj, Audrey Ragagnin, & Julie D. Atkin. (2018). Rab-dependent cellular trafficking and amyotrophic lateral sclerosis. Critical Reviews in Biochemistry and Molecular Biology. 53(6). 623–651. 13 indexed citations
6.
Parakh, Sonam, Cyril J. Jagaraj, Marta Vidal, et al.. (2018). ERp57 is protective against mutant SOD1-induced cellular pathology in amyotrophic lateral sclerosis. Human Molecular Genetics. 27(8). 1311–1331. 29 indexed citations
7.
Shahheydari, Hamideh, Audrey Ragagnin, Adam K. Walker, et al.. (2017). Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum. Frontiers in Molecular Neuroscience. 10. 119–119. 47 indexed citations
8.
Perri, Emma R., Sonam Parakh, & Julie D. Atkin. (2016). Protein Disulphide Isomerases: emerging roles of PDI and ERp57 in the nervous system and as therapeutic targets for ALS. Expert Opinion on Therapeutic Targets. 21(1). 37–49. 20 indexed citations
9.
Perri, Emma R., Colleen J. Thomas, Sonam Parakh, Damian M. S. Spencer, & Julie D. Atkin. (2016). The Unfolded Protein Response and the Role of Protein Disulfide Isomerase in Neurodegeneration. Frontiers in Cell and Developmental Biology. 3. 80–80. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026